Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 February, 2018 05:23 IST
Sun Pharma receives EIR from USFDA for Dadra facility
Source: IRIS | 12 Oct, 2017, 10.23AM
Comments  |  Post Comment

Sun Pharmaceutical Industries has received an Establishment Inspection Report (EIR) from the US Food Drug and Administration (USFDA) in respect of Dadra facility based upon the company’s responses to the observation letter.

EIR is issued to the entity when the USFDA concludes that an inspection is closed under Title 21 Section 20.64 (d) (3) of Code of Federal Regulation.

Total volume of shares traded on the bourses today was lower by 42.34% to 3,573,833 compared with 22-day average volume of 6,197,935.

Shares of the company gained Rs 9.55, or 1.82%, to trade at Rs 535.35. The total volume of shares traded was 193,487 at the BSE (10.07 a.m., Thursday).



Sun Pharmaceutical Industries Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Dilip Buildcon secures EPC road project worth Rs 6.70 bn - 16-Feb-2018 15:39
BHEL commissions 18 MW hydro-electric project in Punjab - 16-Feb-2018 13:33
Reliance Communication update on asset monetization - 16-Feb-2018 12:06
8K Miles Software launches blockchain platform 8K Health Edge - 16-Feb-2018 10:16
Mahindra Group to invest Rs 1.76 bn in Zoomcar - 16-Feb-2018 10:06
India Grid Trust acquires 3 project SPVs - 16-Feb-2018 09:56
Larsen & Toubro bags orders worth Rs 15.85 bn - 15-Feb-2018 13:11
Rajesh Exports wins export order worth Rs 8.73 bn - 15-Feb-2018 12:36
Torrent Power secures wind power projects worth 499.8 MW - 15-Feb-2018 10:09
Torrent Power signs agreement with Siemens Gamesa Renewable Power - 15-Feb-2018 10:08
Zee Learn inks pact to invest Rs 2 bn in MT Educare - 15-Feb-2018 10:01
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer